Blake Wise - Net Worth and Insider Trading

Blake Wise Net Worth

The estimated net worth of Blake Wise is at least $17,102 dollars as of 2024-05-09. Blake Wise is the CEO of Achaogen Inc and owns about 684,066 shares of Achaogen Inc (AKAOQ) stock worth over $17,102. Details can be seen in Blake Wise's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Blake Wise has not made any transactions after 2019-02-21 and currently still holds the listed stock(s).

Transaction Summary of Blake Wise

To

Blake Wise Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Blake Wise owns 2 companies in total, including Calithera Biosciences Inc (CALA) , and Achaogen Inc (AKAOQ) .

Click here to see the complete history of Blake Wise’s form 4 insider trades.

Insider Ownership Summary of Blake Wise

Ticker Comapny Transaction Date Type of Owner
CALA Calithera Biosciences Inc 2017-09-20 director
AKAOQ Achaogen Inc 2019-02-21 Chief Executive Officer

Blake Wise Latest Holdings Summary

Blake Wise currently owns a total of 1 stock. Blake Wise owns 684,066 shares of Achaogen Inc (AKAOQ) as of February 21, 2019, with a value of $17,102.

Latest Holdings of Blake Wise

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AKAOQ Achaogen Inc 2019-02-21 684,066 0.03 17,102

Holding Weightings of Blake Wise


Blake Wise Form 4 Trading Tracker

According to the SEC Form 4 filings, Blake Wise has made a total of 0 transactions in Achaogen Inc (AKAOQ) over the past 5 years. The most-recent trade in Achaogen Inc is the sale of 3,771 shares on February 21, 2019, which brought Blake Wise around $3,356.

Insider Trading History of Blake Wise

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Blake Wise Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Blake Wise Ownership Network

Ownership Network List of Blake Wise

No Data

Ownership Network Relation of Blake Wise


Blake Wise Owned Company Details

What does Calithera Biosciences Inc do?

Who are the key executives at Calithera Biosciences Inc?

Blake Wise is the director of Calithera Biosciences Inc. Other key executives at Calithera Biosciences Inc include director & 10 percent owner Deepika Pakianathan , 10 percent owner Takeda Ventures, Inc. , and SR. VP & CLINICAL DEVELOPMENT Keith Orford .

Calithera Biosciences Inc (CALA) Insider Trades Summary

Over the past 18 months, Blake Wise made no insider transaction in Calithera Biosciences Inc (CALA). Other recent insider transactions involving Calithera Biosciences Inc (CALA) include a net sale of 121,333 shares made by Deepika Pakianathan ,

In summary, during the past 3 months, insiders sold 0 shares of Calithera Biosciences Inc (CALA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 121,333 shares of Calithera Biosciences Inc (CALA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 121,333 shares.

Calithera Biosciences Inc (CALA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Calithera Biosciences Inc Insider Transactions

No Available Data

Blake Wise Mailing Address

Above is the net worth, insider trading, and ownership report for Blake Wise. You might contact Blake Wise via mailing address: C/o Achaogen, Inc., 7000 Shoreline Court, #371, South San Francisco Ca 94080.

Discussions on Blake Wise

No discussions yet.